Effects of levothyroxine on benign thyroid nodules

Not Applicable

• Conditions: Benign Nodule of Thyroid.; Disorders of thyroid gland; E00, E01,

• Registration Number: IRCT201103185692N3
• Lead Sponsor: Bobol University of Medical Siences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

age lower than 60 years old, single thyroid nodule that have benign fine needle aspiration, TSH in normal limit (0.5-4.5 mu/I)
Exclusion criteria: age more than 60, history of hypo or hyperthyroidism, neck radiation, history of any cancer, history of thyroid cancer in family, live in another region where the study is performed, history of levothyroxine or other thyroid related drugs, TSH lower or higher than normal, pregnancy, other disease (cardiovascular or hepatic and)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Size of benign thyroid nodule. Timepoint: Before and 6 months after intervention. Method of measurement: sonography.

Secondary Outcome Measures

Name	Time	Method
TSH. Timepoint: Before, 6 weeks and 6 months after the intervention. Method of measurement: labratory kit.